Evidence-Based Minireview: Molecular precision and clinical uncertainty: should molecular profiling be routinely used to guide risk stratification in MDS?

Abstract excerpt

This is a focused clinical vignette and review of the literature in MDS to discuss the application of molecular sequencing for risk stratification in MDS. The authors utilize an exemplar patient case and explain the advantages and disadvantages, based on available data, of routine use of this testing for MDS patients.

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Clinical Decision-Making
• Share to Myelodysplastic Syndromes
• Share to Phosphoproteins